Jane J. Zara

Array ( [id] => 1406708 [patent_doc_number] => 06534630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Connective tissue growth factor-2' [patent_app_type] => B1 [patent_app_number] => 09/348815 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 12043 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534630.pdf [firstpage_image] =>[orig_patent_app_number] => 09348815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413728 [patent_doc_number] => 06521454 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Baculoviruses, insecticidal compositions, and methods for control of invertebrates' [patent_app_type] => B1 [patent_app_number] => 09/345236 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86346 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521454.pdf [firstpage_image] =>[orig_patent_app_number] => 09345236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699240 [patent_doc_number] => 07067495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-27 [patent_title] => 'Compositions and methods for tumour therapy' [patent_app_type] => utility [patent_app_number] => 09/340595 [patent_app_country] => US [patent_app_date] => 1999-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12175 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067495.pdf [firstpage_image] =>[orig_patent_app_number] => 09340595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4100894 [patent_doc_number] => 06100090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Antisense inhibition of PI3K p85 expression' [patent_app_type] => 1 [patent_app_number] => 9/344521 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26631 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100090.pdf [firstpage_image] =>[orig_patent_app_number] => 344521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349595 [patent_doc_number] => 06291245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Host-vector system' [patent_app_type] => 1 [patent_app_number] => 9/344888 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12047 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291245.pdf [firstpage_image] =>[orig_patent_app_number] => 344888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386562 [patent_doc_number] => 06262249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Pancreatic cancer genes' [patent_app_type] => 1 [patent_app_number] => 9/337171 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11699 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262249.pdf [firstpage_image] =>[orig_patent_app_number] => 337171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373337 [patent_doc_number] => 06562798 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Immunostimulatory oligonucleotides with modified bases and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/324191 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13791 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562798.pdf [firstpage_image] =>[orig_patent_app_number] => 09324191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6815127 [patent_doc_number] => 20030074677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'IMPROVED MATERIALS AND METHODS FOR TRANSFORMATION' [patent_app_type] => new [patent_app_number] => 09/316622 [patent_app_country] => US [patent_app_date] => 1999-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13265 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20030074677.pdf [firstpage_image] =>[orig_patent_app_number] => 09316622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419021 [patent_doc_number] => 06177274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Hepatocyte targeting polyethylene glyco-grafted poly-L-lysine polymeric gene carrier' [patent_app_type] => 1 [patent_app_number] => 9/315240 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 8029 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177274.pdf [firstpage_image] =>[orig_patent_app_number] => 315240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291722 [patent_doc_number] => 06235723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Antisense oligonucleotide modulation of human protein kinase C-.delta. expression' [patent_app_type] => 1 [patent_app_number] => 9/313930 [patent_app_country] => US [patent_app_date] => 1999-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17822 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235723.pdf [firstpage_image] =>[orig_patent_app_number] => 313930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4279126 [patent_doc_number] => 06281329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin' [patent_app_type] => 1 [patent_app_number] => 9/306949 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 15 [patent_no_of_words] => 12889 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281329.pdf [firstpage_image] =>[orig_patent_app_number] => 306949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419412 [patent_doc_number] => 06509452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin' [patent_app_type] => B1 [patent_app_number] => 09/307217 [patent_app_country] => US [patent_app_date] => 1999-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 12613 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509452.pdf [firstpage_image] =>[orig_patent_app_number] => 09307217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5802174 [patent_doc_number] => 20020010143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTION' [patent_app_type] => new [patent_app_number] => 09/307331 [patent_app_country] => US [patent_app_date] => 1999-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8662 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010143.pdf [firstpage_image] =>[orig_patent_app_number] => 09307331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675927 [patent_doc_number] => 07087580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth' [patent_app_type] => utility [patent_app_number] => 09/296264 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 11001 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087580.pdf [firstpage_image] =>[orig_patent_app_number] => 09296264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340850 [patent_doc_number] => 06589940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/296477 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18572 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589940.pdf [firstpage_image] =>[orig_patent_app_number] => 09296477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870583 [patent_doc_number] => 20030083273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'ANTISENSE OLIGOMERS' [patent_app_type] => new [patent_app_number] => 09/295189 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12938 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083273.pdf [firstpage_image] =>[orig_patent_app_number] => 09295189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585174 [patent_doc_number] => 06358741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Connective tissue growth factor (CTGF) and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/292036 [patent_app_country] => US [patent_app_date] => 1999-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 16539 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358741.pdf [firstpage_image] =>[orig_patent_app_number] => 09292036 [rel_patent_id] =>[rel_patent_doc_number] =>)